Opus Genetics IRD
NASDAQ IRD
$4.38 +0.15 (+3.55%)
As of: Nov 11, 2026 · 12:37 PM EST

Opus Genetics (IRD) Price to FCF (2020 - 2023)

Updated

Opus Genetics' (IRD) Price to FCF stood at 3.27 in Q3 2023, down 22.2% from the prior quarter.

Analysis

Opus Genetics (IRD) Price to FCF (2020 - 2023) Analysis & Trends

For FY2022, Opus Genetics' Price to FCF came in at 5.14.

  • Per Business Quant, the preceding three quarters came in at 4.21 (Q2 2023), 4.67 (Q1 2023) and 5.14 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Opus Genetics 405.23 Mn 122.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 3.27
Jun 30, 2023 4.21
Mar 31, 2023 4.67
Dec 31, 2022 5.14
Sep 30, 2020 3.69
Jun 30, 2020 9.47
Mar 31, 2020 167.17
API Access

Opus Genetics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=IRD&period=max&api_key=YOUR_API_KEY